August 23, 2023Lepton Announced Completion of Filing for a Patent Application Extending the Usage of Its Castling Breakthrough Technologies
July 13, 2023Lepton Pharmaceuticals Completed the Extension Worldwide of its International Patent Covering the Breakthrough Castling Technology
March 20, 2023Lepton Pharmaceuticals enter into a Master Service Agreement with Reaction Biology to advance Lepton’s miRNA Castling Technology
July 26, 2022ERS Genomics and Lepton Pharmaceuticals LTD Enter CRISPR/Cas9 License Agreement
February 14, 2022Lepton signs Consulting Agreement with Cell Therapy Expert Dr. Elena Sotillo, Senior Research Scientist at the lab of Prof. Crystal Mackall founding director, Center for Cancer Cell Therapy, Stanford Cancer Institute, Palo Alto, Ca, USA

© 2023 Lepton Pharmaceuticals Inc. All rights reserved
Design & Development by WCT

Our products

Our science